InCytu is a therapeutic device engineering company developing immunotherapeutic and tissue regeneration products to transform personalized medicine. Founded in 2007 and lead by a strong management team, the cornerstone of InCytu's transformative technology platform was developed by Prof. David Mooney at Harvard University. The Company's. WebDec 4, 2009 · 1 December 2009 – Providence, RI – InCytu Incorporated, a therapeutic device engineering company, announced the details of its Cellarium™ Cancer Vaccine program. Cellarium™ is a small bioactive sponge which regulates dendritic cells and T-cells to eliminate normally fatal tumors in a preclinical model of late stage melanoma.

NT-501: an ophthalmic implant of polymer-encapsulated ciliary ...

WebScribd es red social de lectura y publicación más importante del mundo. WebInCytu is an applied biotechnology company developing cell therapy delivery devices which promote targeted tissue healing/regeneration or modulate the immune system. Per the company, InCytu is able to harness and amplify the body's natural regenerative processes using Cellarium's platform technology. The InCytu technology was first developed in ... highbury cases

Top ISTO Technologies Alternatives, Competitors

WebInCytu develops anticancer immunotherapies that use the patient's own immune system to selectively target and destroy tumor cells. Search Crunchbase Start Free Trial WebScientific excellence driven by the need for innovative solutions for patients. Our Passion for Innovation Culture & Careers Passionate individuals bring our ideas to life and help to solve the toughest challenges. Our Awesome Team A source for information and support. Our Patient Support Solve On. Stories Our Inspiration Investor Information WebInCytu has raised a total of $5.1M in funding over 2 rounds. Their latest funding was raised on Jan 13, 2012 from a Venture - Series Unknown round. Funding Rounds. Edit Funding Rounds Section. Number of Funding Rounds 2. Total Funding Amount $5.1M. highbury care home blackpool